정신질환 시장 규모는 향후 몇 년간 강력한 성장이 예상될 예정입니다. 예측 기간의 증가는 스트레스 및 관련 위험 요인의 유병률 증가, 생활 방식 변화로 인한 정신 건강 부담 증가, 정부 이니셔티브 확대, 마음챙김 기반 개입이나 치료 프로그램의 채용 확대, 정신건강 연구나 혁신적 치료에 대한 투자 증가에 기인한다고 생각됩니다. 주요 동향으로서는 신규 약물 요법의 개발, 진단 기술의 진보, 혁신적인 주사약의 도입, 바이오 마커의 이용, 개별화 의약품 수요 증가 등을 들 수 있습니다.
정신 건강 질환의 이환율 증가는 정신질환 시장의 성장을 이끌 것으로 예측됩니다. 스트레스 수준의 증가, 생활 방식의 변화, 사회적 고립, 경제적 압박, 유전적 소인 등의 요인에 기인합니다. 정신질환 치료는 조기 진단, 의료 개입, 전문적 치료를 통해 환자를 서포트해, 항정신질환약의 사용이나 치료법의 선택지를 늘리는 것에 연결됩니다. National Alliance on Mental Illness는 2024년 미국의 18-44세 개인에서 정신질환 스펙트럼과 기분장애가 연간 약 60만 건의 입원을 차지하고 있다고 보고했습니다.
정신질환시장의 기업들은 인터랙티브로 개인화된 정신건강 개입을 통해 치료성과를 높이기 위해 가상현실(VR) 심리요법의 진전에 주력하고 있습니다. 고통을 완화하고, 인지 기능을 개선하고, 유도 개입을 통해 사회적 기술을 높이고, 증상 관리에 대한 안전하고 효과적인 접근법을 제공합니다. 행동요법(CBT)을 통해 환자를 유도하도록 설계된 플랫폼인 gameChangeVR을 발표했습니다. 감소와 전반적인 QOL 향상과 같은 큰 효과가 입증되었습니다. 이 혁신적인 기술은 효과적인 정신 건강에 대한 액세스를 확대하고 임상 의사 부족을 해결하고 심각한 정신 질환을 가진 수백만 명의 환자에게 확장 가능한 솔루션을 제공할 수있는 가능성을 가지고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 정신질환 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계 정신질환 시장 : 성장률 분석
- 세계 정신질환 시장 실적 : 규모와 성장, 2019-2024
- 세계 정신질환 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 정신질환 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 정신질환 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 정제
- 캡슐
- 주사
- 세계의 정신질환 시장 : 질환 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 정신분열증
- 양극성 장애
- 단극성 우울증
- 치매
- 기타 질병의 유형
- 세계의 정신질환 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 온라인
- 오프라인
- 세계의 정신질환 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 헬스케어클리닉
- 전문 클리닉
- 기타 최종 사용자
- 세계의 정신질환 시장 태블릿유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 항정신질환 약 정제
- 기분 안정제
- 세계의 정신질환 시장 캡슐의별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 항정신질환약 캡슐
- 항우울제 캡슐
- 세계의 정신질환 시장, 주사의별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 장시간 작용형 주사 항정신질환약
- 단시간 작용형 주사 항정신질환약
제7장 지역별, 국가별 분석
- 세계의 정신질환 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 정신질환 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 정신질환 시장 : 경쟁 구도
- 정신질환 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Novartis International AG
- GlaxoSmithKline plc
- Takeda Pharmaceuticals Inc.
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Otsuka Pharmaceutical Co.
- Biogen Idec
- Dr. Reddy's Laboratories Ltd.
- Lundbeck A/S
- Gedeon Richter
- Alkermes
- Supernus Pharmaceuticals
- Acadia Pharmaceuticals
- Neuron Pharmaceuticals
- Mapi Pharma
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 정신질환 시장(2029년) : 새로운 기회를 제공하는 국가
- 정신질환 시장(2029년) : 새로운 기회를 제공하는 부문
- 정신질환 시장(2029년) : 성장 전략
제36장 부록
SHW
Psychosis is a mental health condition in which individuals lose touch with reality, experiencing hallucinations, delusions, and disorganized thinking. Rather than being a disorder itself, it is a symptom of various mental illnesses. Early detection enhances treatment outcomes, and effective care through medication, therapy, and support can help individuals regain stability.
The primary types of products for psychosis include tablets, capsules, and injections. Tablets are widely used due to their convenience and precise dosing, ensuring consistent drug levels for effective treatment. The condition encompasses various disease types, including schizophrenia, bipolar disorder, unipolar depression, dementia, and others. These products are distributed through both online and offline channels and are utilized by various end-users, such as hospitals, healthcare clinics, specialty clinics, and others.
The psychosis market research report is one of a series of new reports from The Business Research Company that provides psychosis market statistics, including the psychosis industry global market size, regional shares, competitors with the psychosis market share, detailed psychosis market segments, market trends, and opportunities, and any further data you may need to thrive in the psychosis industry. This psychosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The psychosis market size has grown strongly in recent years. It will grow from $9.88 billion in 2024 to $10.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising cases of mental health conditions, an increasing demand for mental health therapeutics, the widespread adoption of typical antipsychotics, the expanding use of cognitive behavioral therapy, and the prevalence of stress-inducing global and economic conditions.
The psychosis market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the increasing prevalence of stress and associated risk factors, the rising mental health burden due to lifestyle changes, expanding government initiatives, the growing adoption of mindfulness-based interventions and therapy programs, and increasing investments in mental health research and innovative treatments. Major trends include the development of novel drug therapies, advancements in diagnostic technologies, the introduction of innovative injectable drugs, the use of biomarkers, and the growing demand for personalized medicines.
The rising incidence of mental health conditions is expected to drive the growth of the psychosis market. Mental health conditions encompass disorders that affect an individual's mood, thinking, behavior, and overall mental well-being. The increase in these conditions is attributed to factors such as heightened stress levels, lifestyle changes, social isolation, economic pressures, and genetic predisposition. Psychosis treatments support patients through early diagnosis, medical intervention, and specialized therapies, leading to greater use of antipsychotic medications and therapeutic options. For example, in 2024, the National Alliance on Mental Illness, a US-based organization, reported that among individuals in the U.S. aged 18-44, psychosis spectrum and mood disorders account for nearly 600,000 hospitalizations annually. As a result, the rising prevalence of mental health conditions is fueling the growth of the psychosis market.
Companies in the psychosis market are focusing on advancing virtual reality (VR) psychological therapy to enhance treatment outcomes through interactive and personalized mental health interventions. VR psychological therapy involves immersing individuals in controlled, computer-generated environments to reduce distress, improve cognitive function, and enhance social skills through guided interventions, offering a safe and effective approach to symptom management. For instance, in April 2022, OxfordVR, a US-based digital therapeutics company, introduced gameChangeVR, a platform designed to guide patients through cognitive behavioral therapy (CBT) in immersive virtual scenarios. The automated VR therapy, delivered over six weekly sessions, demonstrated significant benefits, particularly for individuals facing severe psychological challenges, by reducing paranoia and enhancing overall quality of life. This innovative technology has the potential to expand access to effective mental health care, addressing clinician shortages and providing a scalable solution for millions of patients with severe mental illness.
In March 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired Karuna Therapeutics for $14 billion. This acquisition aims to strengthen Bristol Myers Squibb's neuroscience portfolio by incorporating KarXT, a novel antipsychotic, and expanding its pipeline with potential treatments for schizophrenia, Alzheimer's disease, and other mental health disorders. Karuna Therapeutics is a US-based biopharmaceutical company specializing in the development of psychosis medications.
Major players in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy's Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics.
North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in psychosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the psychosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The psychosis market consists of sales of transdermal patches, nasal sprays, intravenous (IV) infusions, long-acting injectable (LAI) implants, and inhalable formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Psychosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on psychosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for psychosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The psychosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Tablet; Capsule; Injection
- 2) By Disease Type: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Disease Types
- 3) By Distribution Channel: Online; Offline
- 4) By End-User: Hospitals; Healthcare Clinics; Speciality Clinics; Other End-Users
- Subsegments:
- 1) By Tablet: Antipsychotic Tablets; Mood Stabilizer Tablets
- 2) By Capsule: Antipsychotic Capsules; Antidepressant Capsules
- 3) By Injection: Long-acting Injectable Antipsychotics; Short-acting Injectable Antipsychotics
- Companies Mentioned:Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bristol-Myers Squibb Company; AstraZeneca plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Psychosis Market Characteristics
3. Psychosis Market Trends And Strategies
4. Psychosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Psychosis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Psychosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Psychosis Market Growth Rate Analysis
- 5.4. Global Psychosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Psychosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Psychosis Total Addressable Market (TAM)
6. Psychosis Market Segmentation
- 6.1. Global Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablet
- Capsule
- Injection
- 6.2. Global Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Schizophrenia
- Bipolar Disorder
- Unipolar Depression
- Dementia
- Other Disease Types
- 6.3. Global Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Online
- Offline
- 6.4. Global Psychosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Healthcare Clinics
- Speciality Clinics
- Other End-Users
- 6.5. Global Psychosis Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antipsychotic Tablets
- Mood Stabilizer Tablets
- 6.6. Global Psychosis Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antipsychotic Capsules
- Antidepressant Capsules
- 6.7. Global Psychosis Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Long-acting Injectable Antipsychotics
- Short-acting Injectable Antipsychotics
7. Psychosis Market Regional And Country Analysis
- 7.1. Global Psychosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Psychosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Psychosis Market
- 8.1. Asia-Pacific Psychosis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Psychosis Market
- 9.1. China Psychosis Market Overview
- 9.2. China Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Psychosis Market
- 10.1. India Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Psychosis Market
- 11.1. Japan Psychosis Market Overview
- 11.2. Japan Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Psychosis Market
- 12.1. Australia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Psychosis Market
- 13.1. Indonesia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Psychosis Market
- 14.1. South Korea Psychosis Market Overview
- 14.2. South Korea Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Psychosis Market
- 15.1. Western Europe Psychosis Market Overview
- 15.2. Western Europe Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Psychosis Market
- 16.1. UK Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Psychosis Market
- 17.1. Germany Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Psychosis Market
- 18.1. France Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Psychosis Market
- 19.1. Italy Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Psychosis Market
- 20.1. Spain Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Psychosis Market
- 21.1. Eastern Europe Psychosis Market Overview
- 21.2. Eastern Europe Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Psychosis Market
- 22.1. Russia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Psychosis Market
- 23.1. North America Psychosis Market Overview
- 23.2. North America Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Psychosis Market
- 24.1. USA Psychosis Market Overview
- 24.2. USA Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Psychosis Market
- 25.1. Canada Psychosis Market Overview
- 25.2. Canada Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Psychosis Market
- 26.1. South America Psychosis Market Overview
- 26.2. South America Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Psychosis Market
- 27.1. Brazil Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Psychosis Market
- 28.1. Middle East Psychosis Market Overview
- 28.2. Middle East Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Psychosis Market
- 29.1. Africa Psychosis Market Overview
- 29.2. Africa Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Psychosis Market Competitive Landscape And Company Profiles
- 30.1. Psychosis Market Competitive Landscape
- 30.2. Psychosis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Psychosis Market Other Major And Innovative Companies
- 31.1. Novartis International AG
- 31.2. GlaxoSmithKline plc
- 31.3. Takeda Pharmaceuticals Inc.
- 31.4. Eli Lilly and Company
- 31.5. Teva Pharmaceutical Industries Ltd.
- 31.6. Otsuka Pharmaceutical Co.
- 31.7. Biogen Idec
- 31.8. Dr. Reddy's Laboratories Ltd.
- 31.9. Lundbeck A/S
- 31.10. Gedeon Richter
- 31.11. Alkermes
- 31.12. Supernus Pharmaceuticals
- 31.13. Acadia Pharmaceuticals
- 31.14. Neuron Pharmaceuticals
- 31.15. Mapi Pharma
32. Global Psychosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Psychosis Market
34. Recent Developments In The Psychosis Market
35. Psychosis Market High Potential Countries, Segments and Strategies
- 35.1 Psychosis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Psychosis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Psychosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
